Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Kshirsagar, IN
Amol Kshirsagar, Bangalore IN
| Patent application number | Description | Published |
|---|---|---|
| 20090002032 | DATA SYNCHRONIZER - A data synchronizer is to avoid the pulse width constraint on the data while synchronizing the data between two devices operating at different clock rates. The data synchronizer may comprise one or more storage units such as the flip-flops and a clock gating logic associated with each storage unit. The clock gating logic may generate a control signal which may either allow or stall the clock reaching the storage units. The control signal may be generated by comparing the input and the output to the storage units. | 01-01-2009 |
Jagadish Trimbak Kshirsagar, Pune IN
| Patent application number | Description | Published |
|---|---|---|
| 20100051127 | ARRANGEMENTS FOR PUMPING FLUIDS FROM SUMPS - An arrangement for drawing fluid from a sump ( | 03-04-2010 |
Meghana Kshirsagar, Bangalore IN
| Patent application number | Description | Published |
|---|---|---|
| 20090216739 | BOOSTING EXTRACTION ACCURACY BY HANDLING TRAINING DATA BIAS - Methods and apparatus are described for use with information extraction techniques based on sequential models. Additional statistics are maintained during inference and employed to boost the accuracy of the extraction algorithm and mitigate the effects of training bias. | 08-27-2009 |
| 20100223214 | AUTOMATIC EXTRACTION USING MACHINE LEARNING BASED ROBUST STRUCTURAL EXTRACTORS - A method and apparatus for automatically extracting information from a large number of documents through applying machine learning techniques and exploiting structural similarities among documents. A machine learning model is trained to have at least 50% accuracy. The trained machine learning model is used to identify information attributes in a sample of pages from a cluster of structurally similar documents. A structure-specific model of the cluster is created by compiling a list of top-K locations for each attribute identified by the trained machine learning model in the sample. These top-K lists are used to extract information from the pages of the cluster from which the sample of pages was taken. | 09-02-2010 |
Prakash Kshirsagar, Pune IN
| Patent application number | Description | Published |
|---|---|---|
| 20120135965 | AMORPHOUS FOSAMPRENAVIR CALCIUM - The present invention relates to amorphous Fosamprenavir calcium and processes for its preparation, a pharmaceutical composition comprising it and a method for treating a HIV infection therewith. | 05-31-2012 |
Rajendra Kshirsagar, Navi Mumbai IN
| Patent application number | Description | Published |
|---|---|---|
| 20090215908 | TOLL LIKE RECEPTOR (TLR) SIGNALING ANTAGONIST - The present invention relates to novel synthetic toll like receptor antagonist. The present invention in particular provides compounds, methods and compositions for specifically inhibiting immune stimulation involving TLR ligands, especially TLR-4. The compounds are potentially useful in treatment of inflammation, autoimmunity, allergy, asthma, graft rejection, graft versus host disease, infection, sepsis, cancer and immunodeficiency. | 08-27-2009 |
Rajesh Kshirsagar, Bangalore IN
| Patent application number | Description | Published |
|---|---|---|
| 20100216877 | Storage Stable Prostaglandin Product - A prostaglandin composition comprising prostaglandin and a low-density polyethylene container are disclosed. The prostaglandin compositions are stable in polyethylene containers over longer period of time. | 08-26-2010 |
| 20110123610 | EXTENDED RELEASE COMPOSITIONS CONTAINING TOLTERODINE AND PROCESS FOR PREPARING THE SAME - The present invention is directed to an extended release pharmaceutical composition such as tablets and capsules, and in particular to a matrix tablet composition comprising a therapeutically effective quantity of Tolterodine or pharmaceutical acceptable salts thereof incorporated in a hydrophobic matrix comprising water insoluble polymer and wax and a method for the preparation thereof. | 05-26-2011 |
| 20110135723 | PHARMACEUTICAL COMPOSITIONS CONTAINING PREGABALIN - The present invention provides pharmaceutical composition comprising pregabalin that is useful for once daily oral dosing. The present invention further relates to pharmaceutical composition comprising pregabalin that is useful for once daily oral dosing comprising pregabalin and on or more water insoluble components. The present invention preferably relates to a gastro-retentive tablet comprising pregabalin and one or more water insoluble component wherein water insoluble component preferably comprises of combination of ethylcellulose and hydrogenated castor oil. | 06-09-2011 |
| 20110159092 | EXTENDED RELEASE PHARMACEUTICAL COMPOSITION COMPRISING LINEZOLID AND PROCESS FOR PREPARING THE SAME - The present invention provides an extended release pharmaceutical composition suitable for once daily dosing comprising Linezolid or pharmaceutically acceptable salt, derivative, prodrug, metabolite and polymorph thereof and one or more pharmaceutically acceptable excipients and a process of preparing the same. The present invention further provides a method of treating bacterial infections in a mammal comprising administering an extended release, pharmaceutical composition suitable for once daily dosing comprising Linezolid capable of maintaining T>MIC for at least 24 hours. The present invention further provides an extended release pharmaceutical composition suitable for once daily dosing comprising Linezolid so that upon oral administration the maximum concentrations (C | 06-30-2011 |
| 20110318413 | EXTENDED RELEASE FORMULATIONS CONTAINING DARIFENACIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF - The present invention relates to an extended release formulation comprising darifenacin or pharmaceutically acceptable salts thereof and one or more release controlling hydrophobic materials optionally coated with combination of one or more release controlling hydrophobic materials and one or more release controlling hydrophilic materials; wherein said formulation provides controlled release of the darifenacin over the period of 24 hours. The present invention further relates to an extended release formulation comprising darifenacin or pharmaceutically acceptable salts thereof, wherein darifenacin is incorporated in a matrix comprising one or more release controlling hydrophobic materials and one or more release controlling hydrophilic materials. | 12-29-2011 |
Rajesh Kshirsagar, Gujarat IN
| Patent application number | Description | Published |
|---|---|---|
| 20090220663 | Process and composition of preparing granular sucralose for emulating table sugar - A low-calorie solid, pourable composition for emulating sugar, the composition comprising an intense sweetener and at least one low-calorie bulking agent selected from maltodextrin, magnesium oxide, magnesium carbonate, calcium stearate, colloidal silicon dioxide and starch or combinations thereof, and a process for the preparation of said composition. | 09-03-2009 |
| 20100310652 | COATED EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS OF LEVETIRACETAM - An extended release pharmaceutical composition comprising levetiracetam. A coated extended release pharmaceutical composition comprising levetiracetam wherein the core is coated with a rate controlling composition. | 12-09-2010 |
| 20110027358 | VALSARTAN TABLET FORMULATIONS - The present invention relates to a pharmaceutical tablet composition comprising an effective amount of valsartan. The tablet is prepared by wet granulation and exhibits satisfactory disintegration properties. The invention also relates to a process for preparation of a pharmaceutical tablet composition comprising an effective amount of valsartan wherein the process involves a wet granulation step. | 02-03-2011 |
Rajesh Kshirsagar, Vadodara IN
| Patent application number | Description | Published |
|---|---|---|
| 20090030052 | PHARMACEUTICAL TABLET COMPOSITIONS CONTAINING IRBESARTAN - A pharmaceutical tablet composition comprising irbesartan and lactose, said composition being essentially free of surfactant. | 01-29-2009 |
| 20110064807 | EXTENDED RELEASE FORMULATION OF LEVETIRACETAM - An extended release pharmaceutical composition of Levetiracetam with once a day dosage regime and the process of preparing it. The extended release tablet of Levetiracetam is with the core comprising of Levetiracetam and water dispersible rate controlling polymer, and the tablet core is optionally functional coated comprising a combination of water non-dispersible and/or water dispersible polymer. It provides extended therapeutically effective plasma levels over a twenty four hour period with diminished incidences of neuropsychiatric adverse events by eliminating the troughs and peaks of drug concentration in a patients blood plasma, which comprises administering orally to a patient in need thereof, an extended release tablet that provides a peak blood plasma level of Levetiracetam in from about eight to about Sixteen hours. The core is prepared by Wet granulation, Dry granulation or Direct compression and optionally the tablet core is coated either in an coating pan or in and Fluidized bed system. | 03-17-2011 |
| 20110064808 | EXTENDED RELEASE FORMULATION OF LEVETIRACETAM - The present invention relates to extended release pharmaceutical compositions of Levetiracetam and processes for preparing the same. The extended release tablet of Levetiracetam is with a core comprising of Levetiracetam and water dispersible rate controlling polymer, and the tablet core is optionally functional coated comprising a combination of water non-dispersible and/or water dispersible polymer. It provides extended therapeutically effective plasma levels over a twenty four hour period with diminished incidences of neuropsychiatric adverse events by eliminating the troughs and peaks of drug concentration in a patient's blood plasma. The composition also exhibits no food effect. | 03-17-2011 |
Sachin R. Kshirsagar, Karnataka IN
| Patent application number | Description | Published |
|---|---|---|
| 20090014516 | AUTOMATIC GUIDANCE OF VISITOR IN NEW FACILITY THROUGH ACCESS CONTROL SYSTEM INTEGRATION WITH LCD DISPLAY - An automatic guidance system and method directs a person in a defined area. An access control device includes a selectively encoded readable element. An access control device reader is adapted to read the element of the access control device and selectively deny or allow a user access to a predetermined location. A communication device included in the access control device reader directs the user to the predetermined location. | 01-15-2009 |